CytomX Therapeutics IncNASDAQ:CTMX
- LAST PRICE1.3250
- TODAY'S CHANGE (%)-0.0050 (-0.3759%)
- Bid / Lots1.3200/ 58
- Ask / Lots1.3300/ 61
- Open / Previous Close1.3200 / 1.3300
- Day Range
- 52 Week Range
- Volume1,214,117
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CTMX |
|---|---|---|
| 09:32 ET | 18078 | 1.32 |
| 09:34 ET | 22237 | 1.32 |
| 09:36 ET | 15512 | 1.335 |
| 09:38 ET | 9649 | 1.35 |
| 09:41 ET | 355 | 1.36 |
| 09:43 ET | 6328 | 1.37 |
| 09:45 ET | 5153 | 1.37 |
| 09:48 ET | 6023 | 1.365 |
| 09:50 ET | 7628 | 1.372 |
| 09:52 ET | 22970 | 1.385 |
| 09:54 ET | 40809 | 1.38 |
| 09:56 ET | 5500 | 1.37 |
| 09:57 ET | 2865 | 1.38 |
| 09:59 ET | 8357 | 1.36 |
| 10:01 ET | 10625 | 1.3699 |
| 10:03 ET | 1100 | 1.365 |
| 10:06 ET | 5097 | 1.37 |
| 10:08 ET | 5960 | 1.37 |
| 10:10 ET | 2695 | 1.365 |
| 10:12 ET | 2548 | 1.36 |
| 10:14 ET | 12024 | 1.37 |
| 10:15 ET | 9102 | 1.36 |
| 10:17 ET | 27575 | 1.37 |
| 10:19 ET | 4100 | 1.365 |
| 10:21 ET | 4749 | 1.36 |
| 10:24 ET | 2444 | 1.36 |
| 10:26 ET | 1711 | 1.365 |
| 10:28 ET | 1500 | 1.365 |
| 10:30 ET | 1311 | 1.36 |
| 10:32 ET | 2089 | 1.365 |
| 10:33 ET | 8588 | 1.37 |
| 10:35 ET | 7100 | 1.37 |
| 10:37 ET | 2809 | 1.37 |
| 10:39 ET | 23584 | 1.37 |
| 10:42 ET | 12830 | 1.37 |
| 10:44 ET | 35084 | 1.36 |
| 10:46 ET | 5028 | 1.365 |
| 10:48 ET | 81925 | 1.355 |
| 10:50 ET | 7505 | 1.35 |
| 10:51 ET | 10306 | 1.355 |
| 10:53 ET | 2019 | 1.35 |
| 10:55 ET | 11432 | 1.355 |
| 10:57 ET | 7788 | 1.355 |
| 11:00 ET | 3200 | 1.35 |
| 11:02 ET | 2536 | 1.355 |
| 11:04 ET | 2213 | 1.35 |
| 11:06 ET | 4597 | 1.35 |
| 11:08 ET | 2288 | 1.36 |
| 11:09 ET | 2237 | 1.35 |
| 11:11 ET | 3407 | 1.355 |
| 11:13 ET | 2297 | 1.355 |
| 11:15 ET | 25254 | 1.36 |
| 11:18 ET | 1800 | 1.36 |
| 11:20 ET | 3667 | 1.36 |
| 11:22 ET | 2463 | 1.36 |
| 11:24 ET | 1980 | 1.35 |
| 11:26 ET | 2700 | 1.35 |
| 11:27 ET | 1681 | 1.35 |
| 11:29 ET | 1269 | 1.35 |
| 11:31 ET | 14158 | 1.355 |
| 11:33 ET | 1200 | 1.35 |
| 11:36 ET | 2045 | 1.35 |
| 11:38 ET | 1400 | 1.35 |
| 11:40 ET | 14577 | 1.35 |
| 11:42 ET | 1329 | 1.35 |
| 11:44 ET | 4892 | 1.35 |
| 11:45 ET | 1966 | 1.35 |
| 11:47 ET | 1734 | 1.35 |
| 11:49 ET | 16661 | 1.34 |
| 11:51 ET | 13807 | 1.345 |
| 11:54 ET | 3400 | 1.345 |
| 11:56 ET | 2463 | 1.345 |
| 11:58 ET | 1450 | 1.34 |
| 12:00 ET | 900 | 1.34 |
| 12:02 ET | 3985 | 1.33 |
| 12:03 ET | 1900 | 1.33 |
| 12:05 ET | 668 | 1.33 |
| 12:07 ET | 400 | 1.33 |
| 12:09 ET | 1900 | 1.33 |
| 12:12 ET | 500 | 1.33 |
| 12:14 ET | 4109 | 1.335 |
| 12:16 ET | 950 | 1.33 |
| 12:18 ET | 4210 | 1.335 |
| 12:20 ET | 4914 | 1.34 |
| 12:21 ET | 1465 | 1.33 |
| 12:23 ET | 22306 | 1.34 |
| 12:25 ET | 200 | 1.335 |
| 12:27 ET | 6800 | 1.335 |
| 12:30 ET | 400 | 1.34 |
| 12:32 ET | 400 | 1.335 |
| 12:34 ET | 14016 | 1.335 |
| 12:36 ET | 2294 | 1.34 |
| 12:38 ET | 800 | 1.335 |
| 12:39 ET | 1442 | 1.33 |
| 12:41 ET | 600 | 1.335 |
| 12:43 ET | 500 | 1.335 |
| 12:45 ET | 600 | 1.33 |
| 12:48 ET | 6539 | 1.34 |
| 12:50 ET | 2364 | 1.335 |
| 12:52 ET | 1600 | 1.335 |
| 12:54 ET | 1000 | 1.33 |
| 12:56 ET | 1100 | 1.335 |
| 12:57 ET | 12551 | 1.335 |
| 12:59 ET | 700 | 1.33 |
| 01:01 ET | 3159 | 1.32 |
| 01:03 ET | 4786 | 1.32 |
| 01:06 ET | 600 | 1.32 |
| 01:08 ET | 2216 | 1.3299 |
| 01:10 ET | 2140 | 1.325 |
| 01:12 ET | 1899 | 1.32 |
| 01:14 ET | 1121 | 1.32 |
| 01:15 ET | 400 | 1.32 |
| 01:17 ET | 2687 | 1.32 |
| 01:19 ET | 800 | 1.32 |
| 01:21 ET | 7083 | 1.33 |
| 01:24 ET | 3259 | 1.32 |
| 01:26 ET | 900 | 1.32 |
| 01:28 ET | 700 | 1.32 |
| 01:30 ET | 6500 | 1.32 |
| 01:32 ET | 2708 | 1.32 |
| 01:33 ET | 1500 | 1.3215 |
| 01:35 ET | 1100 | 1.32 |
| 01:37 ET | 1909 | 1.32 |
| 01:39 ET | 1100 | 1.32 |
| 01:42 ET | 500 | 1.32 |
| 01:44 ET | 400 | 1.32 |
| 01:46 ET | 800 | 1.325 |
| 01:48 ET | 1709 | 1.325 |
| 01:50 ET | 2459 | 1.325 |
| 01:51 ET | 1000 | 1.32 |
| 01:53 ET | 3758 | 1.32 |
| 01:55 ET | 1800 | 1.32 |
| 01:57 ET | 3965 | 1.32 |
| 02:00 ET | 1600 | 1.32 |
| 02:02 ET | 2227 | 1.32 |
| 02:04 ET | 1423 | 1.32 |
| 02:06 ET | 36471 | 1.3 |
| 02:08 ET | 6707 | 1.29 |
| 02:09 ET | 22839 | 1.29 |
| 02:11 ET | 1700 | 1.29 |
| 02:13 ET | 14108 | 1.29 |
| 02:15 ET | 4626 | 1.29 |
| 02:18 ET | 3710 | 1.29 |
| 02:20 ET | 1637 | 1.285 |
| 02:22 ET | 1810 | 1.2825 |
| 02:24 ET | 2900 | 1.285 |
| 02:26 ET | 2400 | 1.285 |
| 02:27 ET | 55974 | 1.305 |
| 02:29 ET | 1250 | 1.3 |
| 02:31 ET | 4836 | 1.3 |
| 02:33 ET | 55292 | 1.325 |
| 02:36 ET | 5248 | 1.32 |
| 02:38 ET | 2166 | 1.32 |
| 02:40 ET | 2000 | 1.32 |
| 02:42 ET | 1253 | 1.32 |
| 02:44 ET | 1900 | 1.32 |
| 02:45 ET | 1600 | 1.32 |
| 02:47 ET | 1678 | 1.32 |
| 02:49 ET | 1608 | 1.32 |
| 02:51 ET | 4500 | 1.32 |
| 02:54 ET | 2042 | 1.32 |
| 02:56 ET | 2457 | 1.32 |
| 02:58 ET | 3174 | 1.32 |
| 03:00 ET | 3000 | 1.32 |
| 03:02 ET | 29057 | 1.32 |
| 03:03 ET | 2900 | 1.32 |
| 03:05 ET | 4610 | 1.32 |
| 03:07 ET | 2500 | 1.32 |
| 03:09 ET | 2600 | 1.325 |
| 03:12 ET | 4902 | 1.33 |
| 03:14 ET | 2700 | 1.32 |
| 03:16 ET | 2251 | 1.32 |
| 03:18 ET | 1400 | 1.32 |
| 03:20 ET | 1450 | 1.32 |
| 03:21 ET | 3814 | 1.325 |
| 03:23 ET | 2116 | 1.32 |
| 03:25 ET | 2914 | 1.33 |
| 03:27 ET | 3054 | 1.325 |
| 03:30 ET | 2828 | 1.325 |
| 03:32 ET | 9800 | 1.325 |
| 03:34 ET | 3387 | 1.32 |
| 03:36 ET | 3457 | 1.32 |
| 03:38 ET | 11361 | 1.32 |
| 03:39 ET | 4466 | 1.325 |
| 03:41 ET | 5400 | 1.325 |
| 03:43 ET | 14021 | 1.325 |
Jun 18, 2024
CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference, from 8:00AM ET on Tuesday Jun 18, 2024 by Dow Jones
8:00AM ET on Tuesday Jun 18, 2024 by Dow Jones
Jun 17, 2024
DJ CytomX Therapeutics Promotes Chris Ogden to CFO, from 5:12PM ET on Monday Jun 17, 2024 by Dow Jones
5:12PM ET on Monday Jun 17, 2024 by Dow JonesCytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer, from 4:15PM ET on Monday Jun 17, 2024 by Dow Jones
4:15PM ET on Monday Jun 17, 2024 by Dow JonesPress Release: CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer, from 4:15PM ET on Monday Jun 17, 2024 by Dow Jones
4:15PM ET on Monday Jun 17, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
CytomX Therapeutics Inc | 103.6M | 6.7x | --- |
Spero Therapeutics Inc | 69.1M | 3.1x | --- |
2Seventy Bio Inc | 208.2M | -0.9x | --- |
Rigel Pharmaceuticals Inc | 147.7M | -7.4x | --- |
G1 Therapeutics Inc | 129.1M | -4.0x | --- |
Seres Therapeutics Inc | 109.3M | -1.2x | --- |
Company Information
CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company focused on developing novel conditionally activated biologics designed to be localized to the tumor microenvironment. It is advancing potential first-in-class and best-in-class antibody-based therapeutics created using its PROBODY therapeutic technology platform. Its pipeline comprises therapeutic candidates across multiple treatment modalities including antibody-drug conjugates (ADCs), T-cell engagers, and immune modulators such as cytokines. Its clinical-stage pipeline includes CX-904, CX-2051 and CX-801. CX-904 is a conditionally activated T-cell-engaging antibody targeting the epidermal growth factor receptor on tumor cells and the CD3 receptor on T cells and partnered with Amgen in a global co-development alliance. CX-2051 is a conditionally activated ADC directed toward epithelial cell adhesion molecule (EpCAM) with potential applicability across multiple EpCAM-expressing epithelial cancers.
Contact Information
- Headquarters
- 151 Oyster Point Blvd., Suite 400SOUTH SAN FRANCISCO, CA, United States 94080
- Phone
- 650-515-3185
- Fax
- 650-351-0353
Executives
- Chairman of the Board, Chief Executive Officer
- Sean Mccarthy
- Chief Financial Officer
- Chris Ogden
- Senior Vice President, Chief Scientific Officer
- Marcia Belvin
- Senior Vice President, Chief Compliance Officer, General Counsel, Secretary
- Lloyd Rowland
- Senior Vice President, Chief Business Officer and Head of Strategy
- Jeffrey Landau
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $103.6M |
|---|---|
Revenue (TTM) | $119.2M |
Shares Outstanding | 77.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.05 |
EPS | $0.20 |
Book Value | $-0.70 |
P/E Ratio | 6.7x |
Price/Sales (TTM) | 0.9 |
Price/Cash Flow (TTM) | 5.6x |
Operating Margin | 9.08% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
